T. Odagiri et al., The BM2 protein of influenza B virus is synthesized in the late phase of infection and incorporated into virions as a subviral component, J GEN VIROL, 80, 1999, pp. 2573-2581
The influenza B virus genome RNA segment 7 encodes the M1 and BM2 proteins.
The BM2 protein is synthesized by a coupled translational termination-rein
itiation mechanism at the overlapping stop-start pentanucleotide in a bicis
tronic mRNA transcribed from RNA segment 7, However, features and functions
of this protein remain unclear. In this study the BM2 protein was characte
rized by using an antiserum raised to the BM2 protein of influenza virus st
rain B/Yamagata/1/73, In cells infected with B/Yamagata virus the alpha BM2
antibody specifically detected the BM2 protein with a molecular mass of 12
kDa and also a polypeptide with a molecular mass of 17 kDa, When infected
cells were labelled with P-32(i) and immunoprecipitated with the alpha BM2
antibody, the P-32-labelled 17 kDa polypeptide was specifically precipitate
d. In the presence of casein kinase inhibitor CKI-7 the synthesis of the 17
kDa and BM2 proteins was completely suppressed, although other viral prote
ins, except for the polymerase protein, were synthesized normally. These re
sults suggest that the 17 kDa species is a phosphorylated form of the BM2 p
rotein. These species were substantially synthesized in the late phase of i
nfection and localized in the cytoplasm throughout infection, Moreover, the
y were transported to the plasma membrane and thereafter were incorporated
into virions. These results therefore suggest that the BM2 and the 17 kDa p
roteins are necessary for the life-cycle of influenza B virus.